Diagnostic News and Research

RSS

NEJM article distills available data into a compendium about rapid diagnostic tests for COVID-19

A clinical practice article in the New England Journal of Medicine distills available data and clinical experience into a compendium about rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19.

7 Jan 2022

New appropriate use criteria for prostate-specific membrane antigen PET imaging published

The Society of Nuclear Medicine and Molecular Imaging and peer medical groups have issued appropriate use criteria (AUC) for prostate-specific membrane antigen (PSMA) PET imaging.

7 Jan 2022

Researchers identify how a critical schistosomiasis drug works on the molecular level

Independent teams from Texas Biomedical Research Institute and the Medical College of Wisconsin have published two papers in Science Translational Medicine identifying how the only approved drug to treat schistosomiasis, a widespread parasitic worm infection, works on the molecular level.

6 Jan 2022

Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts

Not too long ago the idea of taking, for instance a skin cell and transforming it into a muscle cell was unthinkable. About 10 years ago, however, revolutionary research showed that it is indeed possible to reprogram differentiated adult cells into other types fully capable of conducting new functions.

6 Jan 2022

Efficacy of rapid antigen diagnostic tests for the detection of infectious individuals at mass gatherings

New study findings show that incidence data often underestimates the prevalence of COVID-19 infectious individuals at a given point in time in a population.

5 Jan 2022

New Potocsnak Longevity Institute aims to extend human 'healthspan'

In the not-too-distant future, you'll be able to check into the Human Longevity Laboratory to find out how old you really are, physiologically speaking.

4 Jan 2022

Study suggests increased vaccine breakthrough for SARS-CoV-2 Omicron variant in Houston, Texas

A recent study reveals early signals of substantially increased vaccine breakthrough for the Omicron variant of SARS-CoV-2 in Houston, Texas.

4 Jan 2022

Siemens Healthineers Announces FDA Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test

The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and older (or adult-collected samples from individuals ages 2-13).

From Siemens Healthineers 4 Jan 2022

Sino Biological Establishes New Location in Houston, Texas

Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on ChiNext (SZSE: 301047), provides biological research reagents and related technical contract research services, is pleased to announce its physical geographic expansion, adding a new location in Houston, Texas.

From Sino Biological Inc. 4 Jan 2022

The brains of infants with autism do not tune in with motherese speech

Motherese is a form of simplified, exaggerated melodic speech that parents use to communicate with newborns and young toddlers.

3 Jan 2022

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening.

3 Jan 2022

COVID-19 vaccine appears safe in children aged 5–11 Years

A new report notes menial or nil severe adverse events from vaccination against COVID-19 in children and therefore recommends COVID-19 vaccination among children aged 5-11 years old.

31 Dec 2021

Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants

A new study used in silico approaches for designing a next-generation CD40-targeting vaccine, CD40.

31 Dec 2021

Loss of smell is the best predictor of COVID-19

A large international team of researchers has conducted a crowdsourced cross-sectional study, in which they have investigated the reliability of the olfactory loss (or loss of smell, or anosmia) as a predictor of coronavirus disease 19 (COVID-19).

30 Dec 2021

SUSU researchers identify biological indicators of long-lasting PTSD

War veterans have helped scientists of South Ural State University identify biological indicators which signal whether people have a post-traumatic stress disorder or a susceptibility to it.

30 Dec 2021

Study uses metabolomics to discriminate drug-induced liver injury phenotypes

Drug-induced liver injury (DILI) is an adverse reaction to ingesting a drug, which can appear both in developmental stages, in their clinical use and even after being approved as a drug.

30 Dec 2021

Rapid antigen tests show lower sensitivity for Omicron than for earlier SARS-CoV-2 variants

Researchers carried out an analytical susceptibility test with cultured SARS-CoV-2 Omicron variant in seven antigen-detecting rapid diagnostic (Ag-RDTs).

29 Dec 2021

Study suggests saliva swabs may be more suitable for omicron detection

New study findings reveal that saliva samples are more useful than mid-turbinate samples for the accurate detection of omicron infection.

29 Dec 2021

Pre-existing immunity against influenza can lower SARS-CoV-2 infection burden and spread

A recent study by a team of European researchers demonstrated how antibodies induced by currently circulating influenza A H1N1 strains can cross-react with the important part of the SARS-CoV-2 spike glycoprotein that interacts with the human cell receptor. Their paper is currently available on the medRxiv* preprint server while it undergoes peer review.

28 Dec 2021

Are our bowel habits written in our DNA?

In this interview, News-Medical talks to Dr. Mauro D’Amato about how there could be clues about the regularity of bowel movements within our genes.

24 Dec 2021

Diagnostic News and Research

NEJM article distills available data into a compendium about rapid diagnostic tests for COVID-19

New appropriate use criteria for prostate-specific membrane antigen PET imaging published

Researchers identify how a critical schistosomiasis drug works on the molecular level

Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts

Efficacy of rapid antigen diagnostic tests for the detection of infectious individuals at mass gatherings

New Potocsnak Longevity Institute aims to extend human 'healthspan'

Study suggests increased vaccine breakthrough for SARS-CoV-2 Omicron variant in Houston, Texas

Siemens Healthineers Announces FDA Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test

Sino Biological Establishes New Location in Houston, Texas

The brains of infants with autism do not tune in with motherese speech

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

COVID-19 vaccine appears safe in children aged 5–11 Years

Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants

Loss of smell is the best predictor of COVID-19

SUSU researchers identify biological indicators of long-lasting PTSD

Study uses metabolomics to discriminate drug-induced liver injury phenotypes

Rapid antigen tests show lower sensitivity for Omicron than for earlier SARS-CoV-2 variants

Study suggests saliva swabs may be more suitable for omicron detection

Pre-existing immunity against influenza can lower SARS-CoV-2 infection burden and spread

Are our bowel habits written in our DNA?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News